ALMR

MKT CAP:$1B

Alamar Biosciences, Inc. Common Stock

Market Cap

$1B

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$26.13+$9.13 (+53.71%)

Jul 15, 2026

52W High $28.4252W Low $17.00

Company Details

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that ...

Leadership

Yuling Luo Ph.D.Founder

Co-Founder, Chairman & CEO

Shiping Chen Ph.D.Founder

Co-Founder, COO & Director

Justin J. McAnear

Chief Financial Officer

Timothy Ogden White J.D.

President

Yiyuan Yin Ph.D.Founder

Founder, VP of Technology & Acting Secretary

Xiao-Jun Ma Ph.D.

Chief Technology Officer

Stephen A. Williams M.D., Ph.D.

Chief Scientific Officer

Alex Forrest-Hay

Senior Vice President of Sales

Anna Berdine

Senior Vice President of Marketing

Micah Litow M.B.A.

Senior VP of AI & Strategic Initiatives

IPO Date

Apr 17, 2026

Website

alamarbio.com

Key Metrics TTM

Revenue

$26M

- YoY

Net Income

-$21M

EPS (Diluted)

Free Cash Flow

-$21M

Revenue / Share

$0.38

Gross Margin

55.5%

Operating Margin

-47.4%

Net Margin

-81.9%

FCF Margin

-80.5%

P/S

54.6x

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue by Geography

Revenue by Product

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee